» Articles » PMID: 29758041

Acute Effects of Insulin on Circulating Natriuretic Peptide Levels in Humans

Overview
Journal PLoS One
Date 2018 May 15
PMID 29758041
Citations 7
Authors
Affiliations
Soon will be listed here.
Abstract

Background: The natriuretic peptide hormones play an important role in salt and blood pressure regulation. In observational studies, obesity and insulin resistance have been consistently associated with lower concentrations of natriuretic peptides. It has been proposed that insulin influences natriuretic peptide production.

Objective: We sought to determine the acute effects of insulin administration on natriuretic peptide concentrations.

Methods: 31 men and women (11 lean, 10 overweight, and 10 obese), ages 30-70 years, without cardiovascular disease or overt diabetes underwent a hyperinsulinemic-euglycemic insulin clamp. Plasma concentrations of N-terminal pro atrial natriuretic peptide (NT-proANP) and N-terminal pro B-type natriuretic peptide (NT-proBNP) were measured at baseline and steady-state (the final 30 minutes of the clamp protocol).

Results: From baseline to steady-state, insulin levels increased from a mean level of 9.5 to 176.7 μU/ml (p<0.001). Over this period, circulating NT-proANP concentrations decreased by 9% (-1933 ng/L, p = 0.01). The changes in NT-proANP did not differ between lean, overweight, and obese individuals. Steady-state NT-proANP levels, adjusted for baseline, were lower in individuals with greater insulin resistance, independent of BMI. In contrast to NT-proANP, NT-proBNP levels did not change significantly during the clamp (p = 0.41).

Conclusion: Insulin administration was associated with a moderate decrease in circulating NT-proANP, but not NT-proBNP. The lowest NT-proANP concentrations were found in insulin-resistant individuals. Further investigations are warranted to elucidate potential mechanisms underlying the effects of insulin on the cardiac hormonal axis.

Citing Articles

Plasma Atrial Natriuretic Peptide Predicts Oxidized Low-Density Lipoprotein Levels in Type 2 Diabetes Mellitus Patients Independent of Circulating Adipokine and Cytokine.

Bakillah A, Al Subaiee M, Soliman A, Obeid K, Bashir S, Al Hussaini A Int J Mol Sci. 2025; 26(5).

PMID: 40076485 PMC: 11899485. DOI: 10.3390/ijms26051859.


Insulin Resistance/Hyperinsulinemia, Neglected Risk Factor for the Development and Worsening of Heart Failure with Preserved Ejection Fraction.

Fazio S, Mercurio V, Fazio V, Ruvolo A, Affuso F Biomedicines. 2024; 12(4).

PMID: 38672161 PMC: 11047865. DOI: 10.3390/biomedicines12040806.


Insulin resistance/hyperinsulinemia: an important cardiovascular risk factor that has long been underestimated.

Fazio S, Mercurio V, Tibullo L, Fazio V, Affuso F Front Cardiovasc Med. 2024; 11:1380506.

PMID: 38545338 PMC: 10965550. DOI: 10.3389/fcvm.2024.1380506.


The Negative Impact of Insulin Resistance/Hyperinsulinemia on Chronic Heart Failure and the Potential Benefits of Its Screening and Treatment.

Fazio S, Mercurio V, Affuso F, Bellavite P Biomedicines. 2023; 11(11).

PMID: 38001929 PMC: 10669553. DOI: 10.3390/biomedicines11112928.


A Descriptive Review of the Action Mechanisms of Berberine, Quercetin and Silymarin on Insulin Resistance/Hyperinsulinemia and Cardiovascular Prevention.

Bellavite P, Fazio S, Affuso F Molecules. 2023; 28(11).

PMID: 37298967 PMC: 10254920. DOI: 10.3390/molecules28114491.


References
1.
Kopf D, Muhlen I, Kroning G, Sendzik I, Huschke B, Lehnert H . Insulin sensitivity and sodium excretion in normotensive offspring and hypertensive patients. Metabolism. 2001; 50(8):929-35. DOI: 10.1053/meta.2001.24928. View

2.
Clerico A, Passino C, Franzini M, Emdin M . Cardiac biomarker testing in the clinical laboratory: where do we stand? General overview of the methodology with special emphasis on natriuretic peptides. Clin Chim Acta. 2014; 443:17-24. DOI: 10.1016/j.cca.2014.06.003. View

3.
Mattioli B, Giordani L, Quaranta M, Viora M . Leptin exerts an anti-apoptotic effect on human dendritic cells via the PI3K-Akt signaling pathway. FEBS Lett. 2009; 583(7):1102-6. DOI: 10.1016/j.febslet.2009.02.029. View

4.
Mascareno E, Beckles D, Dhar-Mascareno M, Siddiqui M . Enhanced hypertrophy in ob/ob mice due to an impairment in expression of atrial natriuretic peptide. Vascul Pharmacol. 2009; 51(2-3):198-204. PMC: 2747368. DOI: 10.1016/j.vph.2009.06.005. View

5.
Silswal N, Singh A, Aruna B, Mukhopadhyay S, Ghosh S, Ehtesham N . Human resistin stimulates the pro-inflammatory cytokines TNF-alpha and IL-12 in macrophages by NF-kappaB-dependent pathway. Biochem Biophys Res Commun. 2005; 334(4):1092-101. DOI: 10.1016/j.bbrc.2005.06.202. View